GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » Other Long Term Assets

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) Other Long Term Assets : ¥587 Mil (As of Mar. 2025)


View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co Other Long Term Assets?

China Resources Boya Bio-pharmaceutical Group Co's other long-term assets for the quarter that ended in Mar. 2025 was ¥587 Mil.

China Resources Boya Bio-pharmaceutical Group Co's quarterly other long-term assets increased from Sep. 2024 (¥374 Mil) to Dec. 2024 (¥563 Mil) and increased from Dec. 2024 (¥563 Mil) to Mar. 2025 (¥587 Mil).

China Resources Boya Bio-pharmaceutical Group Co's annual other long-term assets increased from Dec. 2022 (¥223 Mil) to Dec. 2023 (¥330 Mil) and increased from Dec. 2023 (¥330 Mil) to Dec. 2024 (¥563 Mil).


China Resources Boya Bio-pharmaceutical Group Co Other Long Term Assets Historical Data

The historical data trend for China Resources Boya Bio-pharmaceutical Group Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Boya Bio-pharmaceutical Group Co Other Long Term Assets Chart

China Resources Boya Bio-pharmaceutical Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 442.01 267.94 223.08 329.50 562.88

China Resources Boya Bio-pharmaceutical Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 322.97 306.84 374.09 562.88 586.96

China Resources Boya Bio-pharmaceutical Group Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


China Resources Boya Bio-pharmaceutical Group Co Business Description

Traded in Other Exchanges
N/A
Address
Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000
China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.
Executives
Liang Xiao Ming Directors, executives
Li Shou Sun Executives
Zhang Shi Fang Executives
Tu Yan Shi Directors, executives
Chen Bing Executives
Liao Xin Xi Directors, executives
Fan Yi Qin Secretary, Director
Jiang Guo Liang Supervisors
Xu Jian Xin Director
Duan Hong Zhuan Executives
Chen Hai Yan Executives
Hong Da Cheng Director

China Resources Boya Bio-pharmaceutical Group Co Headlines

No Headlines